1. Mannose antibody levels in gastric cancer patients (literature review and clinical and experimental study)
   M. P. Nikulin et al, 2023, Russian Journal of Biotherapy CrossRef
2. sCD163, sCD28, sCD80, and sCTLA-4 as soluble marker candidates for detecting immunosenescence
   Andrea Aprilia et al, 2024, Immunity & Ageing CrossRef
3. Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
   Wei Cao et al, 2019, PeerJ CrossRef
4. Longitudinal expression profiling of CD4+ and CD8+ cells in patients with active to quiescent giant cell arteritis
   Elisabeth De Smit et al, 2018, BMC Medical Genomics CrossRef
5. Macrophages subpopulations in chronic periapical lesions according to clinical and morphological aspects
   Glória Maria De França et al, 2019, Brazilian Oral Research CrossRef
6. The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT
   Greet De Vlieger et al, 2019, Critical Care CrossRef
7. Characterization of Biomarkers in Colorectal Cancer Liver Metastases as a Prognostic Tool
   Sternschuss Michal et al, 2021, Journal of Personalized Medicine CrossRef
8. Circulating levels of FoxP3, M2 (sCD163) and IGF-1 as potential biomarkers associated with Laryngeal Squamous Cell Carcinoma in Tunisian patients
   Nehla Mokni Baizig et al, 2024, Journal of Immunoassay and Immunochemistry CrossRef
9. Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
   Liva K. Stuhr et al, 2023, Cancers CrossRef
10. Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer
    Tong Feng et al, 2024, Clinica Chimica Acta CrossRef
11. The Mannose Receptor: From Endocytic Receptor and Biomarker to Regulator of (Meta)Inflammation
    Hendrik J. P. van der Zande et al, 2021, Frontiers in Immunology CrossRef
12. Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma
    Anna Nikkarinen et al, 2023, Blood Advances CrossRef
13. LECTINS IN ANTI-CANCER STRATEGIES
    M. V. Lakhtin et al, 2018, Acta Biomedica Scientifica (East Siberian Biomedical Journal) CrossRef
14. Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
    Maria K. Skytthe et al, 2020, International Journal of Molecular Sciences CrossRef
15. Soluble Levels of CD163, PD-L1, and IL-10 in Renal Cell Carcinoma Patients
    Sabina Davidsson et al, 2022, Diagnostics CrossRef
16. Is sCD163 a Clinical Significant Prognostic Value in Cancers? A Systematic Review and Meta-Analysis
    Shushu Qian et al, 2020, Frontiers in Oncology CrossRef
17. Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation
    Maria Embgenbroich et al, 2021, Proceedings of the National Academy of Sciences CrossRef